Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Updating neuropathology and neuropharmacology of monoaminergic systems.

Literature DB >> 27302283

Updating neuropathology and neuropharmacology of monoaminergic systems.

Rona R Ramsay¹, Philippe De Deurwaerdère², Giuseppe Di Giovanni^3,4.

Abstract

LINKED ARTICLES: This article is part of a themed section on Updating Neuropathology and Neuropharmacology of Monoaminergic Systems. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v173.13/issuetoc.

Mesh：

Substances：
Biogenic Monoamines

Year: 2016 PMID： 27302283 PMCID： PMC4908203 DOI： 10.1111/bph.13508

Source DB: PubMed Journal: Br J Pharmacol ISSN： 0007-1188 Impact factor: 8.739

19 in total

1. Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease.

Authors: Sylvia Navailles; Bernard Bioulac; Christian Gross; Philippe De Deurwaerdère
Journal: Neurobiol Dis Date: 2010-11-16 Impact factor: 5.996

2. National trends in long-term use of antidepressant medications: results from the U.S. National Health and Nutrition Examination Survey.

Authors: Ramin Mojtabai; Mark Olfson
Journal: J Clin Psychiatry Date: 2014-02 Impact factor: 4.384

3. Serotonin-dopamine interaction: experimental evidence and therapeutic relevance. Preface.

Authors: Giuseppe Di Giovanni; Vincenzo Di Matteo; Ennio Esposito
Journal: Prog Brain Res Date: 2008 Impact factor: 2.453

4. Interdisciplinary chemical approaches for neuropathology.

Authors: Rona R Ramsay; Giuseppe Di Giovanni
Journal: CNS Neurosci Ther Date: 2014-07 Impact factor: 5.243

Review 5. Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis.

Authors: M F Chesselet
Journal: Neuroscience Date: 1984-06 Impact factor: 3.590

Review 6. Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications.

Authors: Philippe De Deurwaerdère; Giuseppe Di Giovanni
Journal: Prog Neurobiol Date: 2016-03-22 Impact factor: 11.685

Review 7. Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia.

Authors: Concepción García; Cristina Palomo-Garo; Yolanda Gómez-Gálvez; Javier Fernández-Ruiz
Journal: Br J Pharmacol Date: 2015-07-31 Impact factor: 8.739

8. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats.

Authors: Manolo Carta; Thomas Carlsson; Deniz Kirik; Anders Björklund
Journal: Brain Date: 2007-04-23 Impact factor: 13.501

Review 9. Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease.

Authors: Orly Weinreb; Tamar Amit; Orit Bar-Am; Moussa B H Youdim
Journal: Br J Pharmacol Date: 2015-12-01 Impact factor: 8.739

10. Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures.

Authors: Marcello Venzi; François David; Joachim Bellet; Anna Cavaccini; Cristiano Bombardi; Vincenzo Crunelli; Giuseppe Di Giovanni
Journal: Neuropharmacology Date: 2016-04-13 Impact factor: 5.250

1 in total

Review 1. The regulatory role of AP-2β in monoaminergic neurotransmitter systems: insights on its signalling pathway, linked disorders and theragnostic potential.

Authors: Mohamed H Al-Sabri; Maryam Nikpour; Laura E Clemensson; Misty M Attwood; Michael J Williams; Mathias Rask-Anderson; Jessica Mwinyi; Helgi B Schiöth
Journal: Cell Biosci Date: 2022-09-08 Impact factor: 9.584

1 in total